Ratings HTG Molecular Diagnostics, Inc.

Equities

HTGMQ

US40434H3021

Delayed OTC Markets 11:57:16 2024-03-28 am EDT 5-day change 1st Jan Change
0.0015 USD 0.00% Intraday chart for HTG Molecular Diagnostics, Inc. 0.00% +15.38%

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

Investor Rating
-
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
-
Earnings Growth
-
EBITDA / Sales
-
Profitability
-
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes